mesalamine has been researched along with Infant, Small for Gestational Age in 1 studies
Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.
Infant, Small for Gestational Age: An infant having a birth weight lower than expected for its gestational age.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Paternal and maternal use of 5-ASA was safe across offspring outcomes; none of the findings reached statistical significance." | 1.72 | The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study. ( Friedman, S; Kjeldsen, J; Nielsen, J; Nørgård, BM, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nørgård, BM | 1 |
| Friedman, S | 1 |
| Kjeldsen, J | 1 |
| Nielsen, J | 1 |
1 other study available for mesalamine and Infant, Small for Gestational Age
| Article | Year |
|---|---|
The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study.
Topics: Child; Cohort Studies; Colitis, Ulcerative; Crohn Disease; Fathers; Female; Humans; Infant, Newborn; | 2022 |